Pathogenetic issues of retinal dystrophies associated with myopia and agerelated macular degeneration
https://doi.org/10.21516/2072-0076-2017-10-4-90-96
Abstract
The article highlights the modern aspects of etiology and pathogenesis of the development of retinal dystrophies associated with myopia and age-related macular degeneration. Special consideration is given to issues of choroidal neovascularization in cases when both pathologies take place. For citations: Alekseev I.B., Nam Ju.A., Nepesova O.M. Pathogenetic issues of retinal dystrophies associated with myopia and age-related macular degeneration. Russian ophthalmological journal. 2017; 10 (4): 90-6. doi: 10.21516/2072-0076-2017-10-4-90-96 (In Russian).
About the Authors
I. B. Alekseev
State Medical Academy of Continuous Post-Graduate Education
Russian Federation
Russian Federation
Ju. A. Nam
State Medical Academy of Continuous Post-Graduate Education
Russian Federation
Russian Federation
O. M. Nepesova
Medical Rehabilitation Centre, Ministry of Economic Development of Russia
Russian Federation
Russian Federation
References
1. Авербах Ф.А., Островская М.Н. Осложненная близорукость как причина инвалидности. Вестник офтальмологии. 1963; 2: 76-8.
2. Авербах Ф.А. Врачебно-трудовая экспертиза при высокой близорукости. Москва: Медицина;1971.
3. Angle J., Wissmann D.A. The epidemiology of myopia. Am. J. Epidemiol. 1980; 111(2): 220-8.
4. Curtin B.J. The myopias: basic science and clinical management. Philadelphia: Harper & Row; 1985.
5. Holden B.A., Fricke T.R., Wilson DA., et. al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123(5):1036-42. doi: 10.1016/j.ophtha.2016.01.006.
6. Либман Е.С., Шахова Е.В. Слепота и инвалидность вследствие патологии органа зрения в России. Вестник офтальмологии. 2006; 1 35-37.
7. Аветисов Э.С. Близорукость. Москва: Медицина; 1999.
8. Avetisov E.S., Savitskaya N.F., Vinetskaya M.I., Iomdina E.N. A study of biochemical and biomechanical qualities of normal and myopic eye sclera in humans of different age groups. Metab. Pediatr. Syst. Ophthalmol. 1984; 7: 183-8.
9. Иомдина Е.Н. Биомеханические и биохимические нарушения склеры при прогрессирующей близорукости и методы их коррекции. В кн.: С.Э. Аветисов, Т.П. Кащенко, А.М. Шамшинова, ред. Зрительные функции и их коррекция у детей. Москва: Медицина; 2006: 163-83.
10. Rada J.A., Shelton S., Norton T. The sclera and myopia. Exp. Eye Res. 2006; 82(2): 185-200. doi:10.1016/j.exer.2005.08.009.
11. McBrien N.A., Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog. Retin. Eye Res. 2003; 22 (3): 307-338.
12. Mc.Brien N.A., Jobling A.I., Gentle A. Biomechanics of the sclera in myopia: extracellular factors. Optom. Vis. Sci. 2009; 86(1): 23-30. doi: 10.1097/OPX.0b013e3181940669
13. Иомдина Е.Н., Тарутта Е.П., Маркосян Г.А. и др. Биомеханические показатели корнеосклеральной оболочки глаза и состояние соединительнотканной системы у детей и подростков с различными формами прогрессирующей миопии. Российская педиатрическая офтальмология. 2013; 1: 18-23.
14. Balacco Gabrieli C., Moramarco A., Regine F., Abdolrahimzadeh B. Correlation between steroid hormones balance and etiopathology of high myopia: clinical trial. In: Myopia Updates. T. Tokoro (ed.). Tokyo: Springer Verlag; 1998. P. 379-82.
15. Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1432-44. doi:10.1056/NEJMoa062655
16. Ryan S., Schachat A.P., Wilkinson C.P., et.al. Retina. 5th Edition. Philadelphia: Elsevier - Saunders; 2013.
17. Saw S.M., Gazzard G., Shih-Yen E.C., Chua W.H. Myopia and associated pathological complications. Ophthalmic and Physiological Optics. 2005; 25(5): 381-91.
18. Adatia F.A., Luong M., Munro M., et al. The Other CNV: A review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents. Survey of Ophthalmology. 2015; 60(3): 204-15.
19. Chan W.M., Ohji M., Lai T.Y., et al. Choroidal neovascularization in pathological myopia: an update in management. British Journal of Ophthalmology. 2005; 89(11): 1522-8.
20. Avila M.P., Weiter J.J., Jalkh A.E., et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology. 1984; 91(12): 1573-81.
21. Rabb M.F, Garoon I, LaFranco F.P. Myopic Macular Degeneration. International Ophthalmology Clinics. 1981; 21(3): 51-69.
22. Авербах Г.И. Об изменениях макулярной зоны при миопической болезни. Офтальмологический журнал. 1987; 5: 283-6.
23. Shih Y.F., Ho T.C., Hsiao C.K., Lin L.L. Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study. Br J Ophthalmol. 2006; 90(5): 546-50. doi:10.1136/bjo.2005.081992.
24. Saka N., Ohno-Matsui K., Shimada N. Long-term changes in axial length in adult eyes with pathologic myopia. Am J Ophthalmol. 2010; 150(4): 562-8. doi:10.1016/j.ajo.2010.05.009.
25. Hayashi K., Ohno-Matsui K., Shimada N. Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology. 2010; 117(8): 1595-611. doi: 10.1016/j.ophtha.2009.11.003
26. Raecker Matthew E., Park Dong-Wouk, Lauer Andreas K. Diagnosis and Treatment of CNV in Myopic Macular Degeneration. EyeNet Magazine, 2015: 35-37.
27. Manzoni O., Prezeau L., Marin P., et al. Nitric Oxide induced blockade of NMDA receptors. Neuron. 1992; 8: 653-62.
28. Roth S. The relationship of ocular factors to the incidence and progression of age-related maculopathy Clin. Neurosci. 1997; 4(5): 216-23.
29. Klein R., Klein B.E., Jensen S.C., et al. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology. 1999; 106(6): 1056-65.
30. Шадричев Ф.Е. Возрастная макулярная дегенерация. Современная оптометрия. 2008; 6:27-43.
31. Rosenfield P.J., Martidis A., Tennant M. Age-related macular degeneration. Ophthalmology: Expert Consult. 3rd ed. Philadelphia, PA: Elsevier Mosby; 2009.
32. Miller J.W. Age-related macular degeneration revisited - piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am. J. Ophthalmol. 2013; 155(1): 1-35. doi: 10.1016/j.ajo.2012.10.018.
33. Бикбов М.М., Файзрахманов Р.Р., Ярмухаметова А.Л. Возрастная макулярная дегенерация. Москва: Апрель; 2013.
34. Гветадзе А.А., Королева И.А. ВМД. Современный взгляд на проблему. Российский медицинский журнал. Клиническая офтальмология. 2015; 1: 37-41.
35. Нероев В.В., Зайцева О.В. Обзор научных исследований эффективности ретиналамина при возрастной макулярной дегенерации. Pоссийский офтальмологический журнал. 2015. 8 (4): 79-82
36. Chakravarthy U., Wong TY, Fletcher A., et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010; 10. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009619/pdf/1471-2415-10-31.pdf
37. Coleman H.R., Chan C.C., Ferris F.R., Chew E.Y. Age-related macular degeneration. Lancet. 2008; 372(9658): 1835-45. doi: 10.1016/S0140-6736(08)61759-6.
38. Игнатьев С.А., Алексеев И.Б., Чернакова Г.М., Клещева Е.А., Нам Ю.А. Возрастная макулярная дегенерация и цитомегаловирус: дискуссионные аспекты патогенеза. Российский офтальмологический журнал. 2015; 8(4): 71-8.
39. Кацнельсон Л.А., Лысенко В.С., Балишанская Т.И. Клинический атлас патологии глазного дна. 3-е изд., Москва: ГЭОТАР-Медиа; 2004.
40. Penfold P.L., Killingsworth M.C., Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefe's Arch. Clin. Exp. Ophthalmol. 1985; 223(2): 69-76.
41. Nakata I., Yamashiro K., Kawaguchi T., et al. Calcium, ARMS2 genotype, and chlamydia pneumoniae infection in early age-related macular degeneration: a multivariate analysis from the Nagahama Study. Scientific reports. 2015; 5: 9345. doi: 10.1038/srep09345.
42. Wolf-Schnurrbusch U.E., Hess R., Jordi F., et al. Detection of Chlamydia and complement factors in neovascular membranes of patients with age-related macular degeneration. Ocular immunology and inflammation. 2013; 21(1): 36-43. doi: 10.3109/09273948.2012.726393.
43. O’Connor S., Taylor C., Campbell L.A., Epstein S., Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerging infectious diseases. 2001; 7(5): 780-8.
44. Dal Canto A.J., Virgin H.W. 4th. Animal models of infection mediated vasculitis: implications for human disease. International journal of cardiology. 2000; 75 (1): 37-57.
45. Prasad A., Zhu J., Halcox J.P., et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002; 106(2): 184-90.
46. Zhu J., Nieto F.J., Horne B.D., et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001; 103(1): 45-51.
47. Hsich E., Zhou Y.F., Paigen B., et al. Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis. 2001; 156(1): 23-8.
48. Miller D.M., Espinosa-Heidmann D.G., Legra J., et al. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am. Journ. Ophthalmol. 2004; 138(3): 323-28. doi:10.1016/j.ajo.2004.03.018
49. Lavanya R., Kawasaki R., Tay W.T., et al. Hyperopic refractive error and shorter axial length are associated with age-related macular degeneration: the Singapore Malay Eye Study. Invest Ophthalmol Vis Sci. 2010; 51(12): 6247-52. doi:10.1167/iovs.10-5229
50. Xu L., Li Y., Zheng Y., Jonas J.B. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol. 2006; 90 (9): 1087-90. doi:10.1136/bjo.2006.096123
51. Ohno-Matsui K., Kawasaki R., Jonas J. B, et al. International photographic classification and grading system for myopic maculopathy. American journal of ophthalmology. 2015; 159(5):877-83. doi: 10.1016/j.ajo.2015.01.022
52. Faghihi H., Hajizadeh F., Riazi-Esfahani M. Optical Coherence Tomographic Findings in Highly Myopic Eyes. J Ophthalmic Vis Res. 2010; 5(2): 110-21.
53. Cohen S.Y., Laroche A., Leguen Y., Soubrane G., Coscas G.J. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996; 103(8): 1241-4.
54. Hampton G.R., Kohen D., Bird A.C. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983; 90 (8): 923-6.
55. Щуко А.Г., Зайцева Н.В., Злобин И.В., Малышев В.В. Ингибиторы ангиогенеза в лечении различных видов сосудистой и неоваскулярной патологии глаза. Офтальмохирургия. 2012; 2: 30-5.
56. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology. 2001; 108(5):841-52.
57. Gass J.D.M. Stereoscopic Atlas of Macular Disease. St Louis: Mosby Co; 1997.
58. Hayashi K., Ohno-Matsui K., Shimada N., et al. Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology. 2010; 117(8):1595-611. doi: 10.1016/j.ophtha.2009.11.003.
59. Ohno-Matsui K., Yoshida T., Futagami S., et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 2003; 87(5): 570-3.
60. Далидович А.А. Диагностика миопической макулопатии. Офтальмология в Беларуси. 2011; 2:68-78.
61. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996; 86(3): 353-64.
62. Fried M., Siebert A., Meyer-Schwickerath G.A. natural history of Fuchs’ spot: a long term follow-up study. Doc Ophthalmol. 1981; 28: 215-221.
63. Hotchkiss M.L., Fine S.L. Pathologic myopia and choroidal neovascularization. Am J Ophthalmol. 1981; 91(2): 177-83.
64. Hogan A., Behan U., Kilmartin D.J. Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation. Br. J. Ophthalmol. 2005; 89: 1109-11. doi:10.1136/bjo.2004.063024
65. Curtin B., Karlin D. Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol. 1971; 68: 42-53
66. Ikuno Y., Jo Y., Hamasaki T., Tano Y. Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol Vis Sci. 2010; 51: 3721-5. doi: 10.1167/iovs.09-3493.
67. Lam D.S., Chan W.M., Liu D.T., et al. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes-a prospective series of one and two years follow-up. Br. J. Ophthalmol. 2004; 88(10): 1315-19. doi:10.1136/bjo.2004.041624.
68. Shiose S., Hata Y., Noda Y., et al. Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF. Graefes Arch Clin Exp Ophthalmol. 2004; 242(9): 777-83. doi:10.1007/s00417-004-0910-2.
69. Neelam K., Cheung C.M., Ohno-Matsui K., et al. Choroidal neovascularization in pathological myopia. Prog Retin Eye Res. 2012; 31(5): 495-525. doi: 10.1016/j.preteyeres.2012.04.001.
70. Wakabayashi T, Ikuno Y. Choroidal filling delay in choroidal neovascularisation due to pathological myopia. Br. J. Ophthalmol. 2010; 94(5): 611-5. doi: 10.1136/bjo.2009.163535.
71. Curtin B, Karlin D. Axial length measurements and fundus changes of the myopic eye. I. The posterior fundus. Trans. Am. Ophthalmol. Soc. 1970; (68): 312-34.
72. Lihteh Wu. Choroidal Neovascularization Follow-up. Medscape. 2017. Available at: http://emedicine.medscape.com/article/1190818- followup
73. Brown G.C., Murphy R.P. Visual symptoms associated with choroidal neovascularization. Photopsias and the Charles Bonnet syndrome. Arch. Ophthalmol. 1992; 110(9):1251-6.
74. Gass J.D.M., Jallow S., Davis B. Adult vitelliform macular detachment occurring in patients with basal laminar drusen. American Journal of Ophthalmology. 1985; 99(4): 445-59.
75. Guthoff R. Ein Leitfaden fur die Praxis. Ultraschall in der Ophthalmologishen Diagnostik.-Stuttgart. 1988.
76. Kornzweig A.L. The eye in old age. Am. J. Ophthalmol. 1965; 60(5): 835-43.
77. Yannuzzi L.A., Sorenson J., Spaide R.F., Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990; 10(1): 1-8.
78. Yannuzzi L.A., Wong D.W., Sforzolini B.S., et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch. Ophthalmol. 1999; 117(11): 1503-10.
79. Yannuzzi L. A., Negrao S., Iida T., et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001; 21(5): 416-34.
80. Кацнельсон Л.А. Криптоновая лазеркоагуляция субретинальных неоваскулярных мембран. Вестник офтальмологии. 1985; 4: 33-6.
81. Нероев В.В. Российское наблюдательное эпидемиологическое неинтервенционное исследование пациентов с влажной формой возрастной макулярной дегенерации. Российский офтальмологический журнал. 2011; 4(2):4-9.
82. Панова И.Е., Прокопьева М.Ю., Тонких Н.А., Бухтиярова Н.В. Возрастная макулярная дегенерация с неоваскулярным ответом: особенности клинического течения, характеристика клеточного иммунитета. Вестник Оренбургского Государственного Университета. 2004; 13:246-8.
Review
For citations:
Alekseev I.B., Nam J.A., Nepesova O.M. Pathogenetic issues of retinal dystrophies associated with myopia and agerelated macular degeneration. Russian Ophthalmological Journal. 2017;10(4):90-96. (In Russ.) https://doi.org/10.21516/2072-0076-2017-10-4-90-96
Views:
814
Email this article 